News

Articles

FDA granted Quanterix’s neurofilament light chain plasma test a breakthrough device designation as a prognostic aid for relapsing-remitting multiple sclerosis.

FDA Grants Quanterix Plasma Test Breakthrough Device Designation

VYDURA has been granted marketing authorization by the European Commission for both acute treatment of migraine and prophylaxis of episodic migraine. 

Migraine Treatment Granted Marketing Authorization by European Commission 

Moderna has filed for emergency use authorization of its COVID-19 vaccine for use in young children six months to under six years of age.

Moderna Submits EUA of COVID-19 Vaccine for Use in Young Children

ENHERTU has been granted breakthrough therapy designation in the US for patients with HER2 low metastatic breast cancer.

ENHERTU Granted Breakthrough Therapy Designation in US

FDA has granted regenerative medicine advanced therapy (RMAT) designation to Autolus’ CAR-T cell therapy obe-cel. 

FDA Grants RMAT Designation to Autolus’ CAR-T Cell Therapy

GeoVax has received a patent for its malaria vaccine from the US Patent and Trademark Office.

USPTO Issues Malaria Vaccine Patent to GeoVax

Pfizer and BioNTech have submitted an application for Emergency Use Authorization for a COVID-19 vaccine booster dose in young children. 

Pfizer and BioNTech Submit EUA Application for Pediatric COVID-19 Vaccine Booster Dose

Johnson & Johnson has launched its next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town.

Johnson & Johnson Launches Next Satellite Center for Global Health Discovery

Tremelimumab has been accepted under priority review in the US for patients with unresectable liver cancer in combination with Imfinzi.

Tremelimumab Accepted Under Priority Review in the US

FDA has approved Veklury to treat COVID-19 in pediatric patients under 12 years of age.

Biopharma News